Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 19.70% and Operating profit at 35.46% over the last 5 years
2
The company has declared Positive results for the last 4 consecutive quarters
3
With ROE of 16.38%, it has a fair valuation with a 4.73 Price to Book Value
4
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.21%
0%
6.21%
6 Months
9.44%
0%
9.44%
1 Year
61.64%
0%
61.64%
2 Years
20.25%
0%
20.25%
3 Years
122.27%
0%
122.27%
4 Years
138.69%
0%
138.69%
5 Years
0%
0%
0.0%
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

Shandong Bailong Chuangyuan Hits Day High with 5.05% Surge in Stock Price
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. has demonstrated strong market performance, achieving a notable gain and outperforming the China Shanghai Composite over the past year. The company reported positive financial metrics and consistent operational results, solidifying its position in the FMCG sector with significant year-to-date growth.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.70%
EBIT Growth (5y)
35.46%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.56
Tax Ratio
10.65%
Dividend Payout Ratio
19.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.36%
ROE (avg)
13.03%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
4.73
EV to EBIT
25.11
EV to EBITDA
18.95
EV to Capital Employed
5.35
EV to Sales
6.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.30%
ROE (Latest)
16.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
334.00
310.90
7.43%
Operating Profit (PBDIT) excl Other Income
127.40
122.50
4.00%
Interest
1.10
0.80
37.50%
Exceptional Items
0.10
-1.00
110.00%
Consolidate Net Profit
88.40
81.40
8.60%
Operating Profit Margin (Excl OI)
302.40%
309.00%
-0.66%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 7.43% vs -4.87% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 8.60% vs 29.21% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,142.00
860.60
32.70%
Operating Profit (PBDIT) excl Other Income
338.60
240.90
40.56%
Interest
2.90
2.40
20.83%
Exceptional Items
1.30
2.70
-51.85%
Consolidate Net Profit
245.60
193.00
27.25%
Operating Profit Margin (Excl OI)
226.50%
224.70%
0.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 32.70% vs 20.21% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 27.25% vs 27.98% in Dec 2023
About Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. 
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






